Who invested in Adicet Bio?
Adicet Bio's investors include OrbiMed, KB Investment, Novartis, JJDC and Regeneron Pharmaceuticals, and 1 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$175Mraised across 3 rounds since 2015, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $80M sold, first sale Jul 2019
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Aug 2015
From Adicet Bio's own website and the SEC filings it signed: 11 on the team.
On the board, as filediAsish XavierAya JakobovitsCarl GordonErez ChimovitsMichal SilverbergYair Schindel
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Adicet Bio's investors include OrbiMed, KB Investment, Novartis, JJDC and Regeneron Pharmaceuticals, and 1 more on record.
Adicet Bio has raised $175M across 3 rounds since 2015.
Adicet Bio's most recent round was an Undisclosed round of $80M in Oct 2025.
Its most recent round, $80M in Oct 2025, is also its largest on record.
Adicet Bio's first round on record, in Oct 2019, was backed by JJDC, Regeneron Pharmaceuticals and aMoon2 Fund.
Adicet Bio's latest named round is an Undisclosed round, in Oct 2025.
Adicet Bio is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.